CAU
FLGT icon

Caxton Associates (UK)’s Fulgent Genetics FLGT Stock Holding History

Caxton Associates (UK)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
+62,069
New +$1.05M 0.02% 361
2025
Q4 		– Sell
-54,250
Closed -$1.23M – 828
2025
Q3 		$1.23M Sell
54,250
-13,511
-20% -$278K 0.03% 294
2025
Q2 		$1.35M Buy
67,761
+4,898
+8% +$95.5K 0.03% 268
2025
Q1 		$1.06M Buy
+62,863
New +$1.07M 0.04% 308

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caxton Associates (UK)'s FLGT Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 62,069 shares worth $1.27M. The stake represents 0.02% of the portfolio and ranks #361 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in FLGT as recently as Q3 2025.

Caxton Associates (UK) first reported a position in FLGT in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.35M in Q2 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Caxton Associates (UK) held 62,069 shares of Fulgent Genetics worth $1.27M as of Q2 2026.
  • Fulgent Genetics was a new Caxton Associates (UK) position in Q2 2026.
  • Fulgent Genetics made up 0.02% of Caxton Associates (UK)'s portfolio in Q2 2026, its #361 holding.
  • Caxton Associates (UK) first reported a position in Fulgent Genetics in Q1 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Fulgent Genetics position peaked at $1.35M in Q2 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.